Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7950 results

Sort By:

A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

Study ID: NCT06106360
Start Date: 2023-10-26
End Date: 2025-11-26
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Locus Health iPhone App

Sponsor

Inova Health Care Services

Source: clinicaltrials.gov

Share:
Add to list

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Study ID: NCT03206060
Start Date: 2017-10-10
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

130

Intervention / Treatment

LU-177-Dotate

Ga-68-Dotate

F-18-FDG

Amino Acid solution

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion

Study ID: NCT06689176
Start Date: 2024-08-01
End Date: 2025-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Irrisept® Antimicrobial Wound Lavage

Sponsor

Icahn School of Medicine at Mount Sinai

Source: clinicaltrials.gov

Share:
Add to list

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

Study ID: NCT05425576
Start Date: 2025-06
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

63

Intervention / Treatment

OT-101

Sponsor

Oncotelic Inc.

Source: clinicaltrials.gov

Share:
Add to list

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Study ID: NCT04697576
Start Date: 2021-10-20
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

Ipilimumab

Nivolumab

Pembrolizumab

Quadrivalent Inactivated Influenza Vaccine

Resection

Nivolumab + Relatlimab

Sponsor

Carlo Contreras

Source: clinicaltrials.gov

Share:
Add to list

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Study ID: NCT05937776
Start Date: 2023-12-11
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Fludeoxyglucose F-18

Gadoterate Meglumine

Contrast-enhanced Magnetic Resonance Imaging

Positron Emission Tomography

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Study ID: NCT06249191
Start Date: 2024-06-13
End Date: 2027-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Biopsy

Biospecimen Collection

Bone Marrow Aspiration and Biopsy

Computed Tomography

Cyclophosphamide

Doxorubicin

Echocardiography

Etoposide

Magnetic Resonance Imaging

Mosunetuzumab

Multigated Acquisition Scan

Positron Emission Tomography

Prednisone

Vincristine

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Study ID: NCT04329494
Start Date: 2020-08-21
End Date: 2026-08-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

49

Intervention / Treatment

Biopsy

Cisplatin

Doxorubicin

Fluorouracil

Intraperitoneal Chemotherapy

Irinotecan

Leucovorin

Mitomycin

Oxaliplatin

Quality-of-Life Assessment

Administration questionnaire

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM)

Study ID: NCT06055894
Start Date: 2023-09-20
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Omega-3

Curcumin

Probiotic

Whole food, plant-based diet (WFPBD)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Study ID: NCT05504291
Start Date: 2022-11-04
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

26

Intervention / Treatment

Biospecimen Collection

Carboplatin

Etoposide

Examination Under Anesthesia

Magnetic Resonance Imaging

Melphalan

Ultrasound Biomicroscopy

Vincristine

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list